S. Harrison

发表

Proteinase‐activated receptor‐1 (PAR‐1) activation contracts the isolated human renal artery in vitro

M. D'Andrea, S. Salvadori, R. Guerrini, 2003, British journal of pharmacology.

Oxaliplatin elicits mechanical and cold allodynia in rodents via TRPA1 receptor stimulation

B. Nilius, A. Cavazzini, N. Marchetti, 2011, PAIN®.

Pharmacological assessment of the duration of action of glycopyrrolate vs tiotropium and ipratropium in guinea‐pig and human airways

G. Villetti, M. Civelli, M. Bergamaschi, 2006, British journal of pharmacology.

Montelukast inhibits inflammatory responses in small airways of the Guinea-pig.

M. Saetta, P. Geppetti, S. Baraldo, 2008, Pulmonary pharmacology & therapeutics.

Effects of alpha calcitonin gene-related peptide in human bronchial smooth muscle and pulmonary artery

D. Groneberg, A. Fischer, P. Geppetti, 2004, Regulatory Peptides.

Dopamine type 2 receptor expression and function in rodent sensory neurons projecting to the airways.

D. Groneberg, D. Lencer, A. Fischer, 2005, American journal of physiology. Lung cellular and molecular physiology.

Evidence that PAR‐1 and PAR‐2 mediate prostanoid‐dependent contraction in isolated guinea‐pig gallbladder

N. Bunnett, R. Guerrini, P. Geppetti, 2000, British journal of pharmacology.

Bradykinin B2 receptors mediate contraction in the normal and inflamed human gallbladder in vitro.

C. Figueroa, R. De Giorgio, N. Bunnett, 2003, Gastroenterology.

Capsaicin-like effects of N-arachidonoyl-dopamine in the isolated guinea pig bronchi and urinary bladder.

V. Di Marzo, L. De Petrocellis, M. Bifulco, 2003, European journal of pharmacology.

Halogenation of a capsaicin analogue leads to novel vanilloid TRPV1 receptor antagonists

G. Appendino, V. Di Marzo, L. De Petrocellis, 2003, British journal of pharmacology.

Substance p.

P. Geppetti, S. Harrison, 2001, The international journal of biochemistry & cell biology.

Substance P released by TRPV1-expressing neurons produces reactive oxygen species that mediate ethanol-induced gastric injury.

D. Nosi, D. Massi, M. Santucci, 2007, Free radical biology & medicine.

Ethanol elicits and potentiates nociceptor responses via the vanilloid receptor-1

D Smart, D. Owen, A. Randall, 2002, Nature Neuroscience.

Antitussive activity of iodo-resiniferatoxin in guinea pigs

A. Zanasi, G. Fontana, P. Geppetti, 2004, Thorax.

Tachykinins in the respiratory tract.

D. Groneberg, A. Fischer, P. Geppetti, 2006, Current drug targets.

Pharmacology of Putative Cough Receptors

P. Geppetti, M. Trevisani, S. Harrison, 2005 .

Protease-activated receptor-2 activation exaggerates TRPV1-mediated cough in guinea pigs.

N. Bunnett, A. Fischer, P. Geppetti, 2006, Journal of applied physiology.

The vanilloid receptor (VR1)‐mediated effects of anandamide are potently enhanced by the cAMP‐dependent protein kinase

T. Bisogno, V. Di Marzo, L. De Petrocellis, 2001, Journal of neurochemistry.

Anandamide Excites Central Terminals of Dorsal Root Ganglion Neurons via Vanilloid Receptor-1 Activation

C. Créminon, M. Matera, P. Geppetti, 2001, The Journal of Neuroscience.

Ethanol dilates coronary arteries and increases coronary flow via transient receptor potential vanilloid 1 and calcitonin gene-related peptide.

P. Bechi, G. Gensini, N. Marchionni, 2006, Cardiovascular research.

Ethanol Causes Inflammation in the Airways by a Neurogenic and TRPV1-Dependent Mechanism

D. Groneberg, C. Créminon, A. Fischer, 2004, Journal of Pharmacology and Experimental Therapeutics.

Neurogenic responses mediated by vanilloid receptor‐1 (TRPV1) are blocked by the high affinity antagonist, iodo‐resiniferatoxin

C. Créminon, John B Davis, P. Geppetti, 2003, British journal of pharmacology.

Hydrogen sulfide causes vanilloid receptor 1‐mediated neurogenic inflammation in the airways

G. Zagli, C. Créminon, P. Nicoletti, 2005, British journal of pharmacology.

rodent sensory neurons projecting to the airways Dopamine type 2 receptor expression and function in

Axel Fischer, Silvia Amadesi, Barbara Maggiore, 2005 .

Bronchodilator Activity of (3R)-3-[[[(3-fluorophenyl)[(3,4,5-trifluorophenyl)methyl]amino] carbonyl]oxy]-1-[2-oxo-2-(2-thienyl)ethyl]-1-azoniabicyclo[2.2.2]octane bromide (CHF5407), a Potent, Long-Acting, and Selective Muscarinic M3 Receptor Antagonist

M. Zaniboni, G. Rossoni, G. Villetti, 2010, Journal of Pharmacology and Experimental Therapeutics.

Insights for Targeting Disorders of Sensation and Inflammation Transient Receptor Potential Channel Axis: Molecular

P. McIntyre, N. Bunnett, B. Canning, 2015 .

TRPV1-mediated cough in guinea pigs Protease-activated receptor-2 activation exaggerates

A. Fischer, P. Geppetti, S. Amadesi, 2006 .